![Andrew Shales](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Shales
Algemeen Directeur bij
Key Positioning Ltd.
Profiel
Andrew D.
Shales is currently the Chief Executive Officer at Key Positioning Ltd. and Resilia Pharmaceuticals, Inc. He previously served as the Chief Operating Officer & Secretary at Multi-Link Telecommunications, Inc. and as the Chief Operating Officer at Auriga Laboratories, Inc. He also held the position of Chief Operating Officer & Secretary at Auriga Laboratories, Inc. from 2006 to 2007.
Shales received his undergraduate degree from King's College (Pennsylvania) in 1986.
Actieve functies van Andrew Shales
| Bedrijven | Functie | Begin |
|---|---|---|
Key Positioning Ltd. | Algemeen Directeur | - |
Resilia Pharmaceuticals , Inc.
 Resilia Pharmaceuticals , Inc. Pharmaceuticals: MajorHealth Technology Resilia Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on acquiring, licensing, and developing high-value but underpromoted and late-stage therapeutics. The company is based in Atlanta, GA. The company supports patients and healthcare providers by offering FDA-approved products such as Ecoza® (econazole nitrate 1% topical foam), Recedo® (topical gel), Neocera™ (advanced cream), and Neosalus® (advanced cream, foam, or lotion), which are available through retail pharmacies and wholesalers. Resilia Pharmaceuticals provides responsible pricing programs and comprehensive resources for physicians and patients, including prescribing information, savings coupons, and channels for reporting adverse events or product quality concerns. The CEO of the company is Andrew D. Shales. | Algemeen Directeur | - |
Eerdere bekende functies van Andrew Shales
| Bedrijven | Functie | Einde |
|---|---|---|
Auriga Laboratories, Inc.
 Auriga Laboratories, Inc. BiotechnologyHealth Technology Engages in the commercialization, licensing and development of prescription pharmaceutical products | Operationeel Directeur | 05-11-2007 |
Multi-Link Telecommunications, Inc.
 Multi-Link Telecommunications, Inc. Wireless TelecommunicationsCommunications Provides integrated voice and fax messaging services for small and medium sized businesses | Operationeel Directeur | 21-07-2006 |
Auriga Laboratories, Inc. /Old/
 Auriga Laboratories, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Operationeel Directeur | 20-07-2006 |
Opleiding van Andrew Shales
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
20
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Multi-Link Telecommunications, Inc.
Multi-Link Telecommunications, Inc. Wireless TelecommunicationsCommunications Provides integrated voice and fax messaging services for small and medium sized businesses | Communications |
Auriga Laboratories, Inc. /Old/
Auriga Laboratories, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
King's College (Pennsylvania)
 King's College (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auriga Laboratories, Inc.
Auriga Laboratories, Inc. BiotechnologyHealth Technology Engages in the commercialization, licensing and development of prescription pharmaceutical products | Health Technology |
Key Positioning Ltd. | |
Resilia Pharmaceuticals , Inc.
Resilia Pharmaceuticals , Inc. Pharmaceuticals: MajorHealth Technology Resilia Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on acquiring, licensing, and developing high-value but underpromoted and late-stage therapeutics. The company is based in Atlanta, GA. The company supports patients and healthcare providers by offering FDA-approved products such as Ecoza® (econazole nitrate 1% topical foam), Recedo® (topical gel), Neocera™ (advanced cream), and Neosalus® (advanced cream, foam, or lotion), which are available through retail pharmacies and wholesalers. Resilia Pharmaceuticals provides responsible pricing programs and comprehensive resources for physicians and patients, including prescribing information, savings coupons, and channels for reporting adverse events or product quality concerns. The CEO of the company is Andrew D. Shales. | Health Technology |
Kies MarketScreener 
